Journal articleChild Adolesc Ment Health · September 2020
The pandemic COVID-19 (SARS-CoV-2) has had a major global impact on the healthcare systems worldwide as they deal with the surge of critically ill persons. Additionally, the preventative measure of stay-at-home orders and closure of nonessential businesses ...
Full textLink to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · March 2015
OBJECTIVE: To evaluate the frequency of adverse events (AEs) across 4 treatment conditions in the Child/Adolescent Anxiety Multimodal Study (CAMS), and to compare the frequency of AEs between children and adolescents. METHOD: Participants ages 7 to 17 year ...
Full textLink to itemCite
Journal articleJ Subst Abuse Treat · January 2015
Methylphenidate (MPH) is commonly prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), and is often used illicitly by young adults. Illicit users often coadminister MPH with marijuana. Little is known about physiologic and subje ...
Full textLink to itemCite
Journal articleChild Adolesc Psychiatr Clin N Am · April 2014
Disasters, war, and terrorism expose millions of children globally to mass trauma with increasing frequency and severity. The clinical impact of such exposure is influenced by a child's social ecology, which is understood in a risk and resilience framework ...
Full textLink to itemCite
Journal articleJ Atten Disord · February 2014
OBJECTIVE: The goal of this study was to assess the efficacy and tolerability of lis-dexamfetamine dimesylate (LDX) as an adjunct to nicotine replacement therapy in adult smokers with ADHD who were undergoing a quit attempt. METHODS: Thirty-two regular adu ...
Full textLink to itemCite
Journal articlePsychiatr Serv · September 1, 2013
OBJECTIVE: The rise in use of antipsychotics among U.S. children is well documented. Compliance rates with current safety-monitoring guidelines are low. In response, the North Carolina Division of Medical Assistance established the Antipsychotics-Keeping I ...
Full textLink to itemCite
Journal articleChild Psychiatry Hum Dev · August 2011
The primary aim of this paper is to examine the characteristics of a large sample of youth with OCD who are partial responders (i.e., still have clinically significant symptoms) to serotonin reuptake inhibitor (SRI) medication. The sample will be described ...
Full textLink to itemCite
Journal articlePediatrics · April 2011
OBJECTIVE: To evaluate the efficacy and tolerability of atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 5- and 6-year-old children. METHODS: This was an 8-week, double-blind, placebo-controlled randomized clinical trial ...
Full textLink to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · April 2010
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the im ...
Link to itemCite
Journal articlePsychopharmacology (Berl) · May 2009
RATIONALE: There has been controversy over the abuse potential of methylphenidate (MPH) in the context of treatment for attention deficit hyperactivity disorder (ADHD). OBJECTIVE: The objective of this study was to compare the reinforcing and subjective ef ...
Full textLink to itemCite
Journal articleChild Adolesc Psychiatry Ment Health · March 25, 2009
BACKGROUND: In 2003, the National Institute of Mental Health funded the Child and Adolescent Psychiatry Trials Network (CAPTN) under the Advanced Center for Services and Intervention Research (ACSIR) mechanism. At the time, CAPTN was believed to be both a ...
Full textLink to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · December 2008
OBJECTIVE: In response to previously published findings of methylphenidate-induced chromosomal changes in children, this study was designed to determine whether methylphenidate- or amphetamine-based drugs induce chromosomal damage (structural aberrations, ...
Full textLink to itemCite
Journal articleArch Pediatr Adolesc Med · September 2007
OBJECTIVE: To test whether adoption of a collaborative consultative service model results in improved patient outcomes. DESIGN: Twelve pediatric practices were randomly assigned to receive access to collaborative consultative services or to a control group ...
Full textLink to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · September 2007
OBJECTIVES: At the 2005 Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP), the Academy's Workgroup on Research conducted a Research Forum entitled "Increasing Research Literacy Through the Adoption of Evidence-Based Practice ...
Full textLink to itemCite
Journal articleChild Adolesc Psychiatr Clin N Am · January 2007
Pediatric psychopharmacology is taught at the Duke University Hospital Child and Adolescent Psychiatry Residency Training Program within the context of an evidence-based medicine model. The basic goal of the course is to develop competence in the psychopha ...
Full textLink to itemCite
Journal articleCNS Spectr · August 2006
INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is a serious neurobehavioral disorder of childhood onset that often persists into adolescence and adulthood. Functional impairments, underachievement, and difficult interpersonal relationships i ...
Full textLink to itemCite
Journal articleChild Adolesc Ment Health · May 2006
Depression as a disorder in childhood began to be increasingly recognised in the 1970s. Epidemiologic community and clinic-based studies have characterised the prevalence, clinical course, and complications of this illness throughout childhood and adolesce ...
Full textLink to itemCite
Journal articleChild Adolesc Psychiatr Clin N Am · April 2005
Evidence-based medicine (EBM) is defined as a set of processes that facilitate the conscientious, explicit, and judicious integration of individual clinical expertise with the best available external clinical evidence from systematic research in making dec ...
Full textLink to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · December 2004
OBJECTIVE: To improve the gathering of adverse events (AEs) in pediatric psychopharmacology by examining the value and acceptability of increasingly detailed elicitation methods. METHOD: Trained clinicians administered the Safety Monitoring Uniform Report ...
Full textLink to itemCite
Journal articlePrimary Psychiatry · January 1, 2004
Historically considered a childhood disorder, the recognition of ADHD in adults is increasing among the public and medical community. Follow-up studies have consistently documented the persistence of ADHD into adulthood, yet disagreement over the degree to ...
Cite
Journal articleMedical Crossfire · November 1, 2003
Once thought to be a disease afflicting only children and adolescents, attention-deficit/hyperactivity disorder (ADHD) is now recognized to persist into adulthood in an estimated 10% to 60% of cases. Displaying the hallmark symptoms of inattention, disorga ...
Cite
Journal articlePsychopharmacol Bull · 2003
Psychiatrists need to update their skills to incorporate advances in psychiatric practice and to do so "at the bedside."To this end, evidence-based medicine (EBM), which is widely used as an educational heuristic in other areas medicine and has begun to ma ...
Link to itemCite
Journal articleJ Am Acad Child Adolesc Psychiatry · May 2001
OBJECTIVE: The aim of this open-label study was to assess the therapeutic benefits, response pattern, and safety of sertraline in children with social anxiety disorder. METHOD: Fourteen outpatient subjects with a primary Axis I diagnosis of social anxiety ...
Full textLink to itemCite
Journal articleJournal of Practical Psychiatry and Behavioral Health · March 1, 1996
The authors present a suggested standardized documentation record that they hope will eventually achieve wider usage, especially in private practice settings. They first discuss current problems caused by a lack of standard documentation and the influence ...
Cite